Spots Global Cancer Trial Database for To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.
Official Title: A Phase 1 Pharmacokinetic Study To Compare the Relative Bioavailability of Two Clinical Formulations of Linifanib in Subjects With Solid Tumors
Study ID: NCT01381341
Conditions
Interventions
Study Description
Brief Summary: A pharmacokinetic study to compare 2 clinical formulations of linifanib.
Detailed Description: This study is designed to evaluate the bioavailability of linifanib from 2 formulations. Subjects may enroll in a separate extension study to continue receiving linifanib after completion of this study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Site Reference ID/Investigator# 51403, Tacoma, Washington, United States
Contact Details
Name: Mark D. McKee, MD
Affiliation: Abbott
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
